Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML

Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML

Abstract: Measurable residual disease (MRD) by multiparametric flow cytometry (MFC) before allogeneic hematopoietic cell transplantation (HCT) identifies patients at high risk of acute myeloid leukemia (AML) relapse, often occurring early after allografting. To examine the role of MFC MRD testing to...

Full description

Saved in:
Bibliographic Details
Main Authors: Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Corentin Orvain, Filippo Milano, Brenda M. Sandmaier, Chris Davis, Ryan S. Basom, Frederick R. Appelbaum, Roland B. Walter
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952924005998
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items